QR kód

Efficacy and safety of RET-TKI in advanced RET-rearranged non-small cell lung cancer in China: a real-world retrospective chart review

Abstract Background Selective RET inhibitors have been approved by the Chinese government for the treatment of RET-rearranged non-small cell lung cancer. This study aimed to illustrate the efficacy and safety of selective RET inhibitors in a real-world clinical context in China. Methods Patients wit...

Celý popis

Uloženo v:
Hlavní autoři: Siyu Lei, Linyan Tian, Lu Yang, Yaning Yang, Junling Li, Xingsheng Hu, Xuezhi Hao, Haiyan Xu, Yan Wang
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2024-11-01
Edice:BMC Cancer
Témata:
Non-small cell lung cancer
RET rearrangement
RET-TKI
Real-world study
On-line přístup:https://doi.org/10.1186/s12885-024-13155-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky